Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Should I buy Viatris shares after a strong Q3 report?
04:55pm, Tuesday, 09'th Nov 2021
Viatris Inc. (NASDAQ: VTRS) shares have advanced more than 5% after the company reported better than expected third-quarter results on Monday. Viatris's business continued to grow throughout the third
Viatris Inc. (VTRS) CEO Michael Goettler on Q3 2021 Results - Earnings Call Transcript
02:43pm, Monday, 08'th Nov 2021
Viatris Inc. (VTRS) CEO Michael Goettler on Q3 2021 Results - Earnings Call Transcript
Viatris (VTRS) Beats on Q3 Earnings & Sales, Tweaks View
11:32am, Monday, 08'th Nov 2021
Viatris (VTRS) beats on Q3 earnings and sales. The company raises the lower end of its annual revenue guidance.
Viatris: A Look At Whether Q3 Sales Can Tilt The Scales
11:12am, Monday, 08'th Nov 2021
Viatris delivered good revenues and free cash flow and raised guidance for the year. Deleveraging has gone well so far in 2021, but has the financial position actually improved?
Viatris (VTRS) Q3 Earnings and Revenues Surpass Estimates
10:01am, Monday, 08'th Nov 2021
Viatris (VTRS) delivered earnings and revenue surprises of 15.12% and 3.85%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Viatris (VTRS) to Report Q3 Earnings: What's in the Cards?
09:12am, Tuesday, 02'nd Nov 2021
Viatris' (VTRS) Q3 earnings might have gained from the solid performance of Viagra, Dymista, and the Thrombosis portfolio.
Fortune's Change The World Report Included 5 Ideal Dividend Dogs
11:01am, Thursday, 28'th Oct 2021
A special report in Fortune Magazine October/November 2021 listed 53 Change The World (CTW) companies using plain old capitalism (including profits) to "address society's unmet needs."
2 Dividend Stocks That Are Dirt Cheap Right Now
10:39am, Monday, 25'th Oct 2021
The market is deeply discounting this pair of income-generating stocks, which should keep delivering for years to come.
There's Money to Be Made With Vertex, Viatris, Incyte and Biogen
11:54am, Sunday, 24'th Oct 2021
A screening of healthcare stocks in the S&P 500 reveals that investors may find plenty of upside in three members of the index, according to an article in Barron's. The analysis showed that Vertex Pha
Could Viatris Stock Help You Retire a Millionaire?
06:15am, Saturday, 23'rd Oct 2021
It depends on how much help you're looking for.
3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%
05:52am, Friday, 22'nd Oct 2021
Analysts are bullish about these bargains.
Cigna's pharmacy benefit unit to prefer cheaper insulin drug from Viatris
07:09am, Wednesday, 20'th Oct 2021
Cigna Corp's pharmacy benefit unit said on Wednesday it will prefer Viatris Inc and Biocon Biologics Ltd's insulin drug Semglee, a cheaper alternative to Sanofi SA's Lantus, on the list of medicines i
Viatris: Trying To Grope The Bottom
07:00am, Wednesday, 20'th Oct 2021
Viatris: Trying To Grope The Bottom
3 No-Brainer Biotech Stocks to Buy Right Now
06:04am, Saturday, 16'th Oct 2021
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run.
Is Viatris a good buy opportunity at the current share price?
01:58pm, Thursday, 14'th Oct 2021
Wall Street's three main indexes are advancing this Thursday; treasury yields are dropping, and buying sentiment remains high. Viatris Inc. (NASDAQ: VTRS) shares are still not able to stabilize above
